2016
The incidence of adverse pathologic characteristics in small renal masses as size increases.
Nawaf C, Rosoff J, Adeniran A, Humphrey P, Shuch B. The incidence of adverse pathologic characteristics in small renal masses as size increases. Journal Of Clinical Oncology 2016, 34: 596-596. DOI: 10.1200/jco.2016.34.2_suppl.596.Peer-Reviewed Original ResearchAdverse pathologic featuresRenal cell carcinomaActive surveillanceLymphovascular invasionPathologic featuresRenal massesAdverse pathologic characteristicsCT1a renal massesHistologic tumor necrosisRenal tumor biopsySelection of patientsSingle-institution databaseType II histologyHigh nuclear gradeTumor size categoriesSmall renal massesSignificant increaseSarcomatoid featuresPathologic characteristicsTumor sizeCell carcinomaPrimary tumorAUA guidelinesHistologic characteristicsLarge tumors
1992
Clonal Origin of Epithelial Ovarian Carcinoma: Analysis by Loss of Heterozygosity, p53 Mutation, and X-Chromosome Inactivation
Jacobs I, Kohler M, Wiseman R, Marks J, Whitaker R, Kerns B, Humphrey P, Berchuck A, Ponder B, Bast R. Clonal Origin of Epithelial Ovarian Carcinoma: Analysis by Loss of Heterozygosity, p53 Mutation, and X-Chromosome Inactivation. Journal Of The National Cancer Institute 1992, 84: 1793-1798. PMID: 1433368, DOI: 10.1093/jnci/84.23.1793.Peer-Reviewed Original ResearchConceptsEpithelial ovarian carcinomaOvarian cancerOvarian carcinomaTumor depositsPrimary tumorPolyclonal diseaseLoss of heterozygosityClonal originSporadic epithelial ovarian carcinomaMultiple tumour depositsMonoclonal originMultiple primary tumorsPrimary ovarian tumorsPrimary ovarian cancerHereditary ovarian cancerPeripheral blood lymphocytesP53 gene mutationsX-chromosome inactivation analysisMetastatic depositsOvarian tumorsBlood lymphocytesPeritoneal surfacePeritoneal mesotheliumClinical strategiesP53 mutations